ArticleCancer research2020

Targeting of CD38 by the Tumor Suppressor miR-26a Serves as a Novel Potential Therapeutic Agent in Multiple Myeloma.

Yi Hu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.